Home » Topics » Regulatory » Patents

Patents
RSS

HIV protease-inhibitory tetronic acids from P&U

Nov. 8, 1996

Hybridon files new patent for antisense oligonucleotides

Nov. 8, 1996

Sankyo discloses natural antibacterial compounds

Nov. 8, 1996

New penems from Suntory

Nov. 8, 1996

Lilly reports 5-HT1F agonists for migraine

Nov. 8, 1996

Novel tachykinin antagonists from Glaxo Wellcome

Nov. 8, 1996

NK1 antagonists described by Merck & Co.

Nov. 8, 1996

Growth hormone secretion stimulants claimed by Merck & Co.

Nov. 1, 1996

Lilly reports long-acting, soluble insulin analogues

Nov. 1, 1996

Hypoglycemic agents disclosed by Yamanouchi

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.